Feasibility and efficacy of a mass switch from latanoprost to bimatoprost in glaucoma patients in a prepaid Health Maintenance Organization.
about
An observational study of bimatoprost 0.01% in patients on prior intraocular pressure-lowering therapy: the Canadian Lumigan(®) RC Early Analysis Review (CLEAR) trialA randomized, controlled comparison of macroscopic conjunctival hyperemia in patients treated with bimatoprost 0.01% or vehicle who were previously controlled on latanoprostAn observational study of bimatoprost 0.01% in treatment-naïve patients with primary open angle glaucoma or ocular hypertension: the CLEAR trial.Efficacy and tolerability of a large scale change in regimen from latanoprost to travoprost in glaucoma patients at the Manhattan Veterans Administration HospitalFirst-line treatment for elevated intraocular pressure (IOP) associated with open-angle glaucoma or ocular hypertension: focus on bimatoprostEfficacy and tolerability of bimatoprost versus travoprost in patients previously on latanoprost: a 3-month, randomised, masked-evaluator, multicentre studyPaired-eye comparison of medical therapies for glaucoma.A review of the use of latanoprost for glaucoma since its launch.Bimatoprost 0.01% or 0.03% in patients with glaucoma or ocular hypertension previously treated with latanoprost: two randomized 12-week trials.Efficacy and safety of bimatoprost in glaucoma and ocular hypertension in non-responder patients.Diurnal IOP control with bimatoprost versus latanoprost in exfoliative glaucoma: a crossover, observer-masked, three-centre study.
P2860
Q33706842-BD1D750A-7AC4-45BE-8493-AE97399C5451Q34399842-95150D4E-20BB-4D5B-BE35-F6088832399AQ36487013-BB616807-85FB-415C-AFBF-E597090DD55BQ37221497-17D78F88-A3A2-413A-8563-CB4950A6EC42Q37239287-DF97F798-870E-4B26-9666-D102BB8B8C59Q37475890-B94353E5-ABFE-48CB-8997-7327FFAFFF02Q37801282-DDB63B7F-4E85-46BE-B42C-44D27D068322Q37986149-197175B2-89D1-41CE-9181-1E43C334B8FBQ38582444-3C4C10F1-549C-4D1A-A7A8-4036EF416595Q38598695-FA81D158-AD8B-4C3A-993C-74EE1536F234Q41828491-A9D30103-29AB-41BB-9939-4089EE9C362A
P2860
Feasibility and efficacy of a mass switch from latanoprost to bimatoprost in glaucoma patients in a prepaid Health Maintenance Organization.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Feasibility and efficacy of a ...... alth Maintenance Organization.
@en
Feasibility and efficacy of a ...... alth Maintenance Organization.
@nl
type
label
Feasibility and efficacy of a ...... alth Maintenance Organization.
@en
Feasibility and efficacy of a ...... alth Maintenance Organization.
@nl
prefLabel
Feasibility and efficacy of a ...... alth Maintenance Organization.
@en
Feasibility and efficacy of a ...... alth Maintenance Organization.
@nl
P2093
P1433
P1476
Feasibility and efficacy of a ...... alth Maintenance Organization.
@en
P2093
Brian J Song
Ervin Fang
Joseph Caprioli
Simon K Law
P304
P356
10.1016/J.OPHTHA.2005.06.031
P577
2005-10-12T00:00:00Z